Fred Alger Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
SL
Fred Alger Management's TNGX Position: Q3 2026 in Review
Fred Alger Management increased its Tango Therapeutics (TNGX) stake by 68% in Q3 2026, buying an estimated $1.23M and bringing the position to 116,139 shares worth $2.9M. The position accounts for 0.01% of the portfolio, ranked #298.
Fred Alger Management first reported a position in TNGX in Q3 2023 and has held it in 6 quarters since. The position peaked at $3.14M in Q1 2026. 257 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.
- Fred Alger Management held 116,139 shares of Tango Therapeutics worth $2.9M as of Q3 2026.
- Fred Alger Management bought 47,101 Tango Therapeutics shares in Q3 2026, an estimated $1.23M.
- Tango Therapeutics made up 0.01% of Fred Alger Management's portfolio in Q3 2026, its #298 holding.
- Fred Alger Management first reported a position in Tango Therapeutics in Q3 2023 and has held it in 6 quarters since.
- Fred Alger Management's Tango Therapeutics position peaked at $3.14M in Q1 2026.
- 257 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.
Based on Fred Alger Management's 13F filing for Q3 2026, filed 16 Nov 2026.